Autologous Bone Marrow–Derived Cells in the Treatment of Liver Disease Patients

Liver transplantation is universally accepted as a “cure” procedure, and yet is not universally applicable for the treatment of end-stage liver diseases (ESLD) because of the shortage of donors, operative complications, risk of rejection, and high cost. Bioartificial liver device is an option to tem...

Descripción completa

Detalles Bibliográficos
Autores principales: AlAhmari, Leenah S., AlShenaifi, Jumanah Y., AlAnazi, Reema A., Abdo, Ayman A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4355864/
https://www.ncbi.nlm.nih.gov/pubmed/25672232
http://dx.doi.org/10.4103/1319-3767.151211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4355864/
https://www.ncbi.nlm.nih.gov/pubmed/25672232
http://dx.doi.org/10.4103/1319-3767.151211

Ejemplares similares